BRCA2: a genetic risk factor for breast cancer (Q34457494)

2 August 2017

1 reference

title

BRCA2: a genetic risk factor for breast cancer (English)

1 reference

2 August 2017

0 references

Manfred Schwab

1

1 reference

2 August 2017

Andreas Claas

series ordinal

2

1 reference

2 August 2017

Larissa Savelyeva

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

175

1 reference

2 August 2017

1

1 reference

2 August 2017

1-8

1 reference

Breast cancer: magnitude of the problem and descriptive epidemiology

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

The increasing incidence of breast cancer since 1982: relevance of early detection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Incidence of female breast cancer among atomic bomb survivors, 1950-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

1 reference

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Projected changes in breast cancer incidence due to the trend toward delayed childbearing.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Genes implicated in hereditary breast cancer syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

The molecular basis and clinical aspects of Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Genetic and hormonal risk factors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Li-Fraumeni syndrome--a molecular and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Identification of germline missense mutations and rare allelic variants in theATM gene in early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Cancer-susceptibility genes. Gatekeepers and caretakers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Lessons learned from BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Murine Brca2: sequence, map position, and expression pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Synergistic actions of Rad51 and Rad52 in recombination and DNA repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Genetic analysis of gamma-ray mutagenesis in yeast. III. Double-mutant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Role of the human RAD51 protein in homologous recombination and double-stranded-break repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

A surfeit of RAD51-like genes?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Chromosomal stability and the DNA double-stranded break connection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Dose-rate effect on induction and repair rate of radiation-induced DNA double-strand breaks in a normal and an ataxia telangiectasia human fibroblast cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

ATM-dependent phosphorylation of nibrin in response to radiation exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Insights into the functions of BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Amplification of oncogenes revisited: from expression profiling to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

BRCA2 associates with acetyltransferase activity when bound to P/CAF

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

BRCA1 mutations in young women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

Breast cancer genetics: what we know and what we need

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900752-2

7 January 2021

10.1016/S0304-3835(01)00752-2

Identifiers

DOI

1 reference

2 August 2017

1 reference